NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1246,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "9152ce0c-d521-4332-9882-616952a4df46",
"title": "eXp World Holdings Q1 Earnings: Misses on EPS Estimates, Revenue Surpasses Expectations",
"description": "Revenue: Reached $943.05 million in Q1 2024, an increase of 11% year-over-year, surpassing estimates of $893.24 million.Net Loss: Reported a net loss of $15.64",
"keywords": "GuruFocus, Article, News, GuruFocus Research, EXPI",
"snippet": "eXp World Holdings Inc (EXPI, Financial) disclosed its financial outcomes for the first quarter ended March 31, 2024, through its 8-K filing on May 1, 2024. The...",
"url": "https://www.gurufocus.com/news/2423960/exp-world-holdings-q1-earnings-misses-on-eps-estimates-revenue-surpasses-expectations",
"image_url": "https://static.gurufocus.com/logos/0C00008K33.png?5",
"language": "en",
"published_at": "2024-05-01T21:12:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EXPI",
"name": "eXp World Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 101.09871,
"sentiment_score": 0.371522,
"highlights": [
{
"highlight": "<em>eXp</em> <em>World</em> <em>Holdings</em> <em>Inc</em> (EXPI, Financial) disclosed its financial outcomes for the first quarter ended March 31, 2024, through its 8-K filing on May 1, 2024. The company, a leader in cloud-based real estate brokerage, reported mixed results with a revenue beat and an earnings miss compared to analyst expectations.",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>eXp</em> <em>World</em> <em>Holdings</em> <em>Inc</em>, which operates eXp Realty®, FrameVR.io, and SUCCESS® Enterprises, saw its revenue increase to $943.05 million, up 11% from $848.45 million in the same quarter last year, surpassing the estimated revenue of $893.24 million.",
"sentiment": 0.7739,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview and Market Position\n\n<em>eXp</em> <em>World</em> <em>Holdings</em> <em>Inc</em> is not just a real estate company but a technology innovator, leveraging its cloud-based platform to transform the traditional real estate landscape.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Financial and Operational Highlights\n\nThe first quarter saw <em>eXp</em> <em>World</em> <em>Holdings</em> achieve significant transaction growth, with agents closing over $37 billion in transactions, marking a 12% increase year-over-year. This growth is a testament to the scalability and effectiveness of eXp's agent-centric model.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Strategic Initiatives and Leadership Commentary\n\nGlenn Sanford, Founder, Chairman, and CEO of <em>eXp</em> <em>World</em> <em>Holdings</em>, emphasized the company's sustained market share gains and the effectiveness of its cloud brokerage model.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Forward Outlook and Analyst Perspectives\n\nDespite the earnings miss, <em>eXp</em> <em>World</em> <em>Holdings</em>' revenue growth and strategic market positioning reinforce its potential for long-term growth. Analysts might remain cautious due to the earnings miss but optimistic about the company's revenue trajectories and market expansion strategies.",
"sentiment": 0.6295,
"highlighted_in": "main_text"
},
{
"highlight": "In conclusion, <em>eXp</em> <em>World</em> <em>Holdings</em> <em>Inc</em> faces challenges in meeting earnings expectations but continues to excel in revenue growth and market expansion. The company's innovative approach and strategic investments in technology and agent development set the stage for future financial and operational success.",
"sentiment": 0.9549,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>eXp</em> <em>World</em> <em>Holdings</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>eXp</em> <em>World</em> <em>Holdings</em> Q1 Earnings: Misses on EPS Estimates, Revenue Surpasses Expectations",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "bb2ae802-5946-458b-a0ae-69bcc5fa0fe1",
"title": "Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business (PAHC)",
"description": "Phibro Animal Health Corporation's deal with Zoetis looks promising, but lackluster performance over many years leaves room for caution. Click for my PAHC update.",
"keywords": "",
"snippet": "Monty Rakusen/DigitalVision via Getty Images\n\nIt has been a very long time since I last covered shares of Phibro Animal Health Corporation (NASDAQ:PAHC). In fac...",
"url": "https://seekingalpha.com/article/4688174-phibro-animal-health-an-interesting-deal-with-zoetis-for-a-struggling-business",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/159615213/image_159615213.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-05-01T20:36:45.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PAHC",
"name": "Phibro Animal Health Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 113.169334,
"sentiment_score": 0.31238,
"highlights": [
{
"highlight": "Monty Rakusen/DigitalVision via Getty Images\n\nIt has been a very long time since I last covered shares of <em>Phibro</em> <em>Animal</em> <em>Health</em> <em>Corporation</em> (<em>NASDAQ:PAHC</em>). In fact, it was 2015 when I believed that the valuation had become full as investors aggressively priced in improvements in the operational performance.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "A Quick Recap\n\nSince its IPO in 2014, <em>Phibro</em> <em>Animal</em> <em>Health</em> saw real momentum through 2015 on the back of healthy organic growth, margin improvements, and a runway for the business to grow.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Trading at $36 per share, the 40 million shares of <em>Phibro</em> <em>Animal</em> <em>Health</em> commanded a $1.44 billion equity valuation, and over $1.7 billion enterprise valuation.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "That being said, I am cautiously awaiting more clues about the Zoetis deal and its implications in the upcoming earnings release before reconsidering a neutral stance on <em>Phibro</em> <em>Animal</em> <em>Health</em> <em>Corporation</em> here.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Phibro</em> <em>Animal</em> <em>Health</em>: An Interesting Deal With Zoetis For A Struggling Business (PAHC)",
"sentiment": -0.0258,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "b7223598-cbf8-4978-b9fd-4fd525887622",
"title": "U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.23% By Investing.com",
"description": "U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.23%",
"keywords": "",
"snippet": "Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the , and sectors led shares higher while losses in the , and sectors led sha...",
"url": "https://www.investing.com/news/stock-market-news/us-stocks-mixed-at-close-of-trade-dow-jones-industrial-average-up-023-3411761",
"image_url": "https://i-invdn-com.investing.com/news/moved_LYNXNPEK33099_L.jpg",
"language": "en",
"published_at": "2024-05-01T20:32:08.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "CETX",
"name": "Cemtrex, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 44.750565,
"sentiment_score": -0.1459,
"highlights": [
{
"highlight": "The worst performers were <em>Cemtrex</em> <em>Inc</em> (NASDAQ: ) which was down 73.20% to 0.31 in late trade, Beneficient (NASDAQ: ) which lost 38.55% to settle at 2.04 and CVRx Inc (NASDAQ: ) which was down 34.75% to 10.12 at the close.",
"sentiment": -0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Shares in <em>Cemtrex</em> <em>Inc</em> (NASDAQ: ) fell to 5-year lows; down 73.20% or 0.83 to 0.31. Shares in CytomX Therapeutics Inc (NASDAQ: ) rose to 52-week highs; rising 214.72% or 3.50 to 5.13. Shares in Beneficient (NASDAQ: ) fell to all time lows; down 38.55% or 1.28 to 2.04.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CETXP",
"name": "Cemtrex, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 44.750565,
"sentiment_score": -0.1459,
"highlights": [
{
"highlight": "The worst performers were <em>Cemtrex</em> <em>Inc</em> (NASDAQ: ) which was down 73.20% to 0.31 in late trade, Beneficient (NASDAQ: ) which lost 38.55% to settle at 2.04 and CVRx Inc (NASDAQ: ) which was down 34.75% to 10.12 at the close.",
"sentiment": -0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Shares in <em>Cemtrex</em> <em>Inc</em> (NASDAQ: ) fell to 5-year lows; down 73.20% or 0.83 to 0.31. Shares in CytomX Therapeutics Inc (NASDAQ: ) rose to 52-week highs; rising 214.72% or 3.50 to 5.13. Shares in Beneficient (NASDAQ: ) fell to all time lows; down 38.55% or 1.28 to 2.04.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "61c1d81c-2f2e-45ea-b704-fe8939e498c0",
"title": "OneSpaWorld Holdings Limited (OSW) Q1 2024 Earnings Call Transcript",
"description": "OneSpaWorld Holdings Limited (NASDAQ:NASDAQ:OSW) Q1 2024 Earnings Conference Call May 1, 2024 11:00 AM ETCompany ParticipantsAllison Malkin - Investor...",
"keywords": "",
"snippet": "OneSpaWorld Holdings Limited (NASDAQ:OSW) Q1 2024 Earnings Conference Call May 1, 2024 11:00 AM ET\n\nCompany Participants\n\nAllison Malkin - Investor Relations, I...",
"url": "https://seekingalpha.com/article/4688203-onespaworld-holdings-limited-osw-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-05-01T20:20:26.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "OSW",
"name": "OneSpaWorld Holdings Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 159.34048,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>OneSpaWorld</em> <em>Holdings</em> <em>Limited</em> (<em>NASDAQ:OSW</em>) Q1 2024 Earnings Conference Call May 1, 2024 11:00 AM ET\n\nCompany Participants\n\nAllison Malkin - Investor Relations, ICR\n\nLeonard Fluxman - President, Executive Chairman & Chief Executive Officer\n\nStephen Lazarus - Chief Operating Officer & Chief Financial Officer\n\nConference Call Participants\n\nSteve Wieczynski",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>OneSpaWorld</em> <em>Holdings</em> <em>Limited</em> (OSW) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "7a7057d6-05f0-4a4f-905c-c1b28fc760fe",
"title": "CPS Technologies Corporation Announces First Quarter 2024 Financial Results",
"description": "Investing to Drive Higher Growth as the Year Progresses...",
"keywords": "Nasdaq:CPSH, CPS Technologies Corp.",
"snippet": "NORTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) (“CPS” or the “Company”) today announced financial results fo...",
"url": "https://www.globenewswire.com/news-release/2024/05/01/2873665/0/en/CPS-Technologies-Corporation-Announces-First-Quarter-2024-Financial-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/91f4960f-2c05-4602-bc3d-03e1914bb19c",
"language": "en",
"published_at": "2024-05-01T20:15:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CPSH",
"name": "CPS Technologies Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 156.97006,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., May 01, 2024 (GLOBE NEWSWIRE) -- <em>CPS</em> <em>Technologies</em> <em>Corporation</em> (<em>NASDAQ:CPSH</em>) (“CPS” or the “Company”) today announced financial results for the fiscal first quarter ended March 30, 2024.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CPS</em> <em>Technologies</em> <em>Corporation</em>\n\n111 South Worcester Street\n\nNorton, MA 02766\n\nwww.cpstechnologysolutions.com\n\nInvestor Relations:\n\nChris Witty\n\n646-438-9385\n\[email protected]\n\n<em>CPS</em> <em>TECHNOLOGIES</em> <em>CORPORATION</em> Statements of Operations (Unaudited) Fiscal Quarters Ended March 30, 2024 April 1, 2023 Revenues: Product sales $ 5,912,634 $ 7,100,267 Total revenues",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CPS</em> <em>Technologies</em> <em>Corporation</em> Announces First Quarter 2024 Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "cd437103-07ee-4407-b101-ef652340f444",
"title": "TTM Technologies Q1 Results Top Estimates; Guides Q2 In Line With View",
"description": "TTM Technologies, Inc. (TTMI) reported Wednesday a net income for the first quarter of $10.47 million or $0.10 per share, compared to a net loss of $5.81 million or $0.",
"keywords": "TTM Technologies, TTMI",
"snippet": "TTM Technologies, Inc. (TTMI) reported Wednesday a net income for the first quarter of $10.47 million or $0.10 per share, compared to a net loss of $5.81 millio...",
"url": "https://www.rttnews.com/3443696/ttm-technologies-q1-results-top-estimates-guides-q2-in-line-with-view.aspx?type=ern",
"image_url": "https://cdn.rttnews.com/images/v4/RTTNews-logo-512x512.png",
"language": "en",
"published_at": "2024-05-01T12:32:51.000000Z",
"source": "rttnews.com",
"relevance_score": null,
"entities": [
{
"symbol": "TTMI",
"name": "TTM Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 80.65315,
"sentiment_score": 0.4364,
"highlights": [
{
"highlight": "<em>TTM</em> <em>Technologies</em>, <em>Inc</em>. (TTMI) reported Wednesday a net income for the first quarter of $10.47 million or $0.10 per share, compared to a net loss of $5.81 million or $0.06 per share in the prior-year quarter.\n\nExcluding items, adjusted net income for the quarter was $0.31 per share, compared to $0.18 per share in the year-ago quarter.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>TTM</em> <em>Technologies</em> Q1 Results Top Estimates; Guides Q2 In Line With View",
"sentiment": 0.2023,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "e61b88af-cf4a-47e3-9634-c466e701f066",
"title": "DLH Reports Fiscal 2024 Second Quarter Results",
"description": "Revenue Grows and Backlog Strengthens as Debt Reduction Continues...",
"keywords": "Nasdaq:DLHC, DLH Holdings Corp.",
"snippet": "ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and develop...",
"url": "https://www.globenewswire.com/news-release/2024/05/01/2873659/0/en/DLH-Reports-Fiscal-2024-Second-Quarter-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/4efe5f34-0462-4275-ac88-2c8a07c2a9b0",
"language": "en",
"published_at": "2024-05-01T20:15:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "DLHC",
"name": "DLH Holdings Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 51.510136,
"sentiment_score": 0.350338,
"highlights": [
{
"highlight": "ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- <em>DLH</em> <em>Holdings</em> <em>Corp</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ</em>: <em>DLHC</em>) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2024.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "About DLH\n\nDLH (<em>NASDAQ</em>: <em>DLHC</em>) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "CONTACTS:\n\nINVESTOR RELATIONS Contact: Chris Witty Phone: 646-438-9385 Email: [email protected] TABLES TO FOLLOW\n\n\n\n\n\n<em>DLH</em> <em>HOLDINGS</em> <em>CORP</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "3,913 3,277 Provision for income tax (benefit) expense (60 ) 381 (50 ) 925 Net income $ 1,812 $ 805 $ 3,963 $ 2,352 Net income per share - basic $ 0.13 $ 0.06 $ 0.28 $ 0.17 Net income per share - diluted $ 0.12 $ 0.06 $ 0.27 $ 0.16 Weighted average common stock outstanding Basic 14,205 13,759 14,118 13,530 Diluted 14,946 14,600 14,823 14,447\n\n\n\n\n\n<em>DLH</em>",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HOLDINGS</em> <em>CORP</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Common stock, $0.001 par value; 40,000 shares authorized; 14,230 and 13,950 shares issued and outstanding at March 31, 2024 and September 30, 2023, respectively 14 14 Additional paid-in capital 100,322 99,974 Retained earnings 6,414 2,451 Total shareholders’ equity 106,750 102,439 Total liabilities and shareholders' equity $ 325,942 $ 339,841\n\n\n\n\n\n<em>DLH</em>",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HOLDINGS</em> <em>CORP</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "9a07edc9-b743-4769-8f99-447c887edaf2",
"title": "Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024",
"description": "MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive...",
"keywords": "OTC Markets:PBLA, Panbela Therapeutics, Inc.",
"snippet": "MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeu...",
"url": "https://www.globenewswire.com/news-release/2024/05/01/2873655/37414/en/Panbela-to-Host-First-Quarter-2024-Earnings-Conference-Call-on-May-15-2024.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a",
"language": "en",
"published_at": "2024-05-01T20:15:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "PBLA",
"name": "Panbela Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 41.74324,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- <em>Panbela</em> <em>Therapeutics</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About Panbela\n\n<em>Panbela</em> <em>Therapeutics</em>, <em>Inc</em>. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. Panbela’s lead assets are Ivospemin (SBP-101) and Flynpovi. Further information can be found at www.panbela.com.",
"sentiment": 0.0516,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "5267d1d6-e5d8-41ab-8360-c6d9d5943f36",
"title": "United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript",
"description": "United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ETCompany ParticipantsDewey Steadman - Head of...",
"keywords": "",
"snippet": "United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ET\n\nCompany Participants\n\nDewey Steadman - Head of Investor R...",
"url": "https://seekingalpha.com/article/4688144-united-therapeutics-corporation-uthr-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-05-01T18:46:13.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "UTHR",
"name": "United Therapeutics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 121.2269,
"sentiment_score": 0.4637,
"highlights": [
{
"highlight": "<em>United</em> <em>Therapeutics</em> <em>Corporation</em> (<em>NASDAQ:UTHR</em>) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ET\n\nCompany Participants\n\nDewey Steadman - Head of Investor Relations\n\nMartine Rothblatt - Chairperson and Chief Executive Officer\n\nMichael Benkowitz - President and Chief Operating Officer\n\nJames Edgemond - Chief Financial Officer and Treasurer\n\nLeigh",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Peterson - Executive Vice President-Product Development and Xenotransplantation\n\nConference Call Participants\n\nTerence Flynn - Morgan Stanley\n\nRoanna Ruiz - Leerink\n\nAsh Verma - UBS\n\nJoseph Thome - TD Cowen\n\nOperator\n\nGood morning and welcome to the <em>United</em> <em>Therapeutics</em> <em>Corporation</em> First Quarter 2024 Earnings Webcast.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at <em>United</em> <em>Therapeutics</em>.\n\nDewey Steadman\n\nThank you, Danielle and good morning. It's my pleasure to welcome you to the <em>United</em> <em>Therapeutics</em> Corporation's first quarter 2024 earnings webcast.",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "Now, I will turn the webcast over to James Edgemond, our CFO and Treasurer for some brief comments on our recent accelerated share repurchase plan, followed by Martine and Michael for an overview of our first quarter 2024 financial results and the business activities of <em>United</em> <em>Therapeutics</em>. James?",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "And so, as you know, at <em>United</em> <em>Therapeutics</em>, we believe on multiple shots on goal. So, in fact, we are developing, we have our 10-gene pig that we have, we're developing two different organs, our 10-gene xeno kidney, as well as our 10-gene xeno heart.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Operator\n\nThank you for participating in today's <em>United</em> <em>Therapeutics</em> <em>Corporation</em> earnings webcast. A rebroadcast of this webcast will be available for replay for one week by visiting the EVENTS AND PRESENTATIONS section of the <em>United</em> <em>Therapeutics</em>' Investor Relations website at ir.unither.com. The conference is now concluded.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Therapeutics</em> <em>Corporation</em> (UTHR) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 12.842705,
"sentiment_score": 0.709275,
"highlights": [
{
"highlight": "Dewey Steadman - Head of Investor Relations\n\nMartine Rothblatt - Chairperson and Chief Executive Officer\n\nMichael Benkowitz - President and Chief Operating Officer\n\nJames Edgemond - Chief Financial Officer and Treasurer\n\nLeigh Peterson - Executive Vice President-Product Development and Xenotransplantation\n\nConference Call Participants\n\nTerence Flynn - <em>Morgan</em>",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Stanley</em>\n\nRoanna Ruiz - Leerink\n\nAsh Verma - UBS\n\nJoseph Thome - TD Cowen\n\nOperator\n\nGood morning and welcome to the United Therapeutics Corporation First Quarter 2024 Earnings Webcast.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Question-and-Answer Session\n\nOperator\n\n[Operator Instructions] The first question comes from Terence Flynn from <em>Morgan</em> <em>Stanley</em>. Please go ahead.\n\nTerence Flynn\n\nGreat. Good morning. Thanks for taking the question. Maybe, a two-part from me. I was just wondering what you're seen now with respect to breadth of prescribing for Tyvaso and ILD.",
"sentiment": 0.936,
"highlighted_in": "main_text"
},
{
"highlight": "Martine Rothblatt\n\nThank you, Terrence and congratulations on being over at <em>Morgan</em> <em>Stanley</em> now. Mike, given the queue, feel free to answer as much of that question as you feel time permits.\n\nMichael Benkowitz\n\nYes, sure. So, on the breadth of prescribing, I mean, overall, we're continuing to see growth in both breadth and depth.",
"sentiment": 0.946,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "8327b543-caad-4350-a69d-905afe06fb54",
"title": "G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript",
"description": "G1 Therapeutics, Inc. (NASDAQ:NASDAQ:GTHX) Q1 2024 Earnings Conference Call May 1, 2024 8:30 AM ETCompany ParticipantsWill Roberts - Investor RelationsJack...",
"keywords": "",
"snippet": "G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Conference Call May 1, 2024 8:30 AM ET\n\nCompany Participants\n\nWill Roberts - Investor Relations\n\nJack Baile...",
"url": "https://seekingalpha.com/article/4688038-g1-therapeutics-inc-gthx-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-05-01T16:04:08.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "GTHX",
"name": "G1 Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 135.47466,
"sentiment_score": 0.16215,
"highlights": [
{
"highlight": "<em>G1</em> <em>Therapeutics</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:GTHX</em>) Q1 2024 Earnings Conference Call May 1, 2024 8:30 AM ET\n\nCompany Participants\n\nWill Roberts - Investor Relations\n\nJack Bailey - Chief Executive Officer\n\nAndrew Perry - Chief Commercial Officer\n\nRaj Malik - Chief Medical Officer\n\nJohn Umstead - Chief Financial Officer\n\nConference Call Participants\n\nGil Blum - Needham\n\nJoseph Thome - TD",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Welcome to the <em>G1</em> <em>Therapeutics</em> First Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>G1</em> <em>Therapeutics</em>, <em>Inc</em>. (GTHX) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "7c3d6feb-b3ad-4344-a8eb-0db71f9f0730",
"title": "Omega Flex, Inc. Announces First Quarter 2024 Earnings",
"description": "OMEGA FLEX, INC. (OFLX) Three Months Ended March 31, 2024 2023 Net Sales$25,216,000 $29,987,000 Net Income attributable to Omega Flex,...",
"keywords": "Nasdaq:OFLX, Omega Flex, Inc.",
"snippet": "OMEGA FLEX, INC. (OFLX) Three Months Ended March 31, 2024 2023 Net Sales $25,216,000 $29,987,000 Net Income attributable to Omega Flex, Inc. $4,219,000 $5,742,0...",
"url": "https://www.globenewswire.com/news-release/2024/05/01/2873658/8168/en/Omega-Flex-Inc-Announces-First-Quarter-2024-Earnings.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/dfa4e168-93d1-49e1-82d2-68848710fccf",
"language": "en",
"published_at": "2024-05-01T20:15:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "OFLX",
"name": "Omega Flex, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 153.03842,
"sentiment_score": -0.0355,
"highlights": [
{
"highlight": "<em>OMEGA</em> <em>FLEX</em>, <em>INC</em>. (OFLX) Three Months Ended March 31, 2024 2023 Net Sales $25,216,000 $29,987,000 Net Income attributable to <em>Omega</em> <em>Flex</em>, <em>Inc</em>. $4,219,000 $5,742,000 Earnings Per Share - Basic and Diluted $0.42 $0.57 Weighted Average Shares - Basic and Diluted 10,094,322 10,094,322\n\nEXTON, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Dean W.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Rivest, CEO, announced that net sales of <em>Omega</em> <em>Flex</em>, <em>Inc</em>. (the “Company” or “<em>Omega</em> <em>Flex</em>”) for the first quarters of 2024 and 2023 were $25,216,000 and $29,987,000, respectively, decreasing 15.9%.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS – This press release contains forward-looking statements, which are subject to inherent uncertainties which are difficult to predict and may be beyond the ability of <em>Omega</em> <em>Flex</em> to control.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance, or achievements of <em>Omega</em> <em>Flex</em> (or entities in which <em>Omega</em> <em>Flex</em> has interests) or industry results, to differ materially from future results, performance or achievements expressed or implied by such",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Omega</em> <em>Flex</em> undertakes no obligation to publicly release the result of any revisions to these forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, conditions, or circumstances.",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Omega</em> <em>Flex</em>, <em>Inc</em>. Announces First Quarter 2024 Earnings",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "74dc50ec-2f79-4e94-968f-fe1dbc5177c2",
"title": "eXp World Holdings Reports Q1 2024 Results",
"description": "BELLINGHAM, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®,...",
"keywords": "Nasdaq:EXPI, eXp World Holdings, Inc., #firstquarterearnings, #investors, #Q1earnings",
"snippet": "BELLINGHAM, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, FrameVR...",
"url": "https://www.globenewswire.com/news-release/2024/05/01/2873667/0/en/eXp-World-Holdings-Reports-Q1-2024-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/e309db78-a212-4779-a436-2ad766ce7818",
"language": "en",
"published_at": "2024-05-01T20:15:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "EXPI",
"name": "eXp World Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 119.40611,
"sentiment_score": 0.327191,
"highlights": [
{
"highlight": "., May 01, 2024 (GLOBE NEWSWIRE) -- <em>eXp</em> <em>World</em> <em>Holdings</em>, <em>Inc</em>. (<em>Nasdaq</em>: <em>EXPI</em>), or the “Company”, the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the first quarter ended March 31, 2024.",
"sentiment": 0.6633,
"highlighted_in": "main_text"
},
{
"highlight": "“During the first quarter, our agents closed over $37 billion of transactions, a 12% year-over-year increase, underscoring eXp’s unparalleled scale in the cloud brokerage market we pioneered,” said Glenn Sanford, <em>eXp</em> <em>World</em> <em>Holdings</em> Founder, Chairman and CEO.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "“We delivered a solid first quarter as we grew revenues 11% year over year while generating significant cash flow and returning $41 million to shareholders through share repurchases and cash dividends,” said Kent Cheng, Principal Financial Officer of <em>eXp</em> <em>World</em> <em>Holdings</em>.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "First Quarter 2024 Results – Virtual Fireside Chat\n\nThe Company will hold a virtual fireside chat and investor Q&A with <em>eXp</em> <em>World</em> <em>Holdings</em> Founder and CEO Glenn Sanford, eXp Realty CEO Leo Pareja and <em>eXp</em> <em>World</em> <em>Holdings</em> Principal Financial Officer and Chief Accounting Officer, Kent Cheng on Wednesday, May 1, 2024 at 2 p.m. PT / 5 p.m. ET.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Join at https://exp.world/earnings\n\nLivestream: expworldholdings.com/events\n\nAbout <em>eXp</em> <em>World</em> <em>Holdings</em>, <em>Inc</em>.\n\n<em>eXp</em> <em>World</em> <em>Holdings</em>, <em>Inc</em>. (<em>Nasdaq</em>: <em>EXPI</em>) is the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises.",
"sentiment": 0.7672,
"highlighted_in": "main_text"
},
{
"highlight": "As a publicly traded company, <em>eXp</em> <em>World</em> <em>Holdings</em> provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. <em>eXp</em> <em>World</em> <em>Holdings</em> and its businesses offer a full suite of brokerage and real estate tech solutions, including an innovative residential and commercial brokerage",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "<em>eXp</em> <em>World</em> <em>Holdings</em>, <em>Inc</em>. intends to use its Investor Relations website, its X (formerly Twitter) feed (@eXpWorldIR), Facebook page (https://www.facebook.com/eXpWorldHoldings), Instagram account (@eXpWorldHoldings), LinkedIn page (https://www.linkedin.com/company/expworldholdings/), as well as eXp Realty, LLC’s X (formerly Twitter) feed (@eXpRealty),",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Media Relations Contact:\n\n<em>eXp</em> <em>World</em> <em>Holdings</em>, <em>Inc</em>.\n\[email protected]\n\nInvestor Relations Contact:\n\nDenise Garcia\n\[email protected]\n\n\n\n\n\n\n\n\n\n<em>EXP</em> <em>WORLD</em> <em>HOLDINGS</em>, <em>INC</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>WORLD</em> <em>HOLDINGS</em>, <em>INC</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>World</em> <em>Holdings</em>, <em>Inc</em>. stockholders' equity 222,437 242,839 Equity attributable to noncontrolling interest - 1,169 TOTAL EQUITY 222,437 244,008 TOTAL LIABILITIES AND EQUITY $ 426,749 $ 385,668 -\n\n\n\n\n\n\n\n<em>EXP</em> <em>WORLD</em> <em>HOLDINGS</em>, <em>INC</em>.",
"sentiment": 0.1197,
"highlighted_in": "main_text"
},
{
"highlight": "<em>eXp</em> <em>World</em> <em>Holdings</em> Reports Q1 2024 Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "2a28bc8b-10fc-4ea0-8006-5982dc92d15d",
"title": "TG Therapeutics stock jumps on Q1 sales beat (NASDAQ:TGTX)",
"description": "TG Therapeutics (TGTX) stock rose after the biotech topped expectations with its Q1 revenue, as sales from its multiple sclerosis drug Briumvi jumped. Read more here.",
"keywords": "",
"snippet": "TG Therapeutics (NASDAQ:TGTX) shares rose ~26% in the premarket on Wednesday after the biotech exceeded expectations with its Q1 2024 revenue, as U.S. sales fro...",
"url": "https://seekingalpha.com/news/4097304-tg-therapeutics-stock-jumps-q1-sales-beat",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/499205246/image_499205246.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2024-05-01T13:24:55.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "TGTX",
"name": "TG Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 102.90097,
"sentiment_score": 0.262825,
"highlights": [
{
"highlight": "<em>TG</em> <em>Therapeutics</em> (<em>NASDAQ:TGTX</em>) shares rose ~26% in the premarket on Wednesday after the biotech exceeded expectations with its Q1 2024 revenue, as U.S. sales from its multiple sclerosis therapy, Briumvi, topped management’s guidance.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "“We were extremely pleased with the strong sales of just over $50 million in Briumvi U.S. net revenue for the first quarter of 2024, which was ahead of our guidance,” <em>TG</em> <em>Therapeutics</em> (TGTX) CEO Michael Weiss remarked.",
"sentiment": 0.7553,
"highlighted_in": "main_text"
},
{
"highlight": "Expecting sales momentum to continue, <em>TG</em> <em>Therapeutics</em> (TGTX) raised its U.S. net product revenue target from Briumvi to $270M-$290M, up from $220M-$260M previously.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>TG</em> <em>Therapeutics</em> stock jumps on Q1 sales beat (<em>NASDAQ:TGTX</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "b70a121e-8d3f-447d-a925-d3ef58b04764",
"title": "New York Mortgage Trust Reports First Quarter 2024 Results",
"description": "NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported...",
"keywords": "Nasdaq:NYMT, New York Mortgage Trust, Inc., EARNINGS, REIT, Real Estate Investment Trust, REAL ESTATE",
"snippet": "NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today r...",
"url": "https://www.globenewswire.com/news-release/2024/05/01/2873651/12581/en/New-York-Mortgage-Trust-Reports-First-Quarter-2024-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/8b301801-e1c9-4019-8da4-3d24e14e183b",
"language": "en",
"published_at": "2024-05-01T20:10:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "YI",
"name": "111, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 3.297188,
"sentiment_score": -0.1591,
"highlights": [
{
"highlight": "1,275 Total other (loss) income (57,323 ) 25,081 GENERAL, ADMINISTRATIVE AND OPERATING EXPENSES: General and administrative expenses 13,054 12,683 Portfolio operating expenses 11,287 7,070 Total general, administrative and operating expenses 24,341 19,753 (LOSS) INCOME FROM OPERATIONS BEFORE INCOME TAXES (80,170 ) 14,178 Income tax (benefit) expense (<em>111</em>",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "loss from real estate (16,369 ) (6,807 ) (7,788 ) (7,755 ) (8,951 ) Total other (loss) income (57,323 ) 40,685 (85,943 ) (19,254 ) 25,081 Total general, administrative and operating expenses 24,341 17,813 16,987 18,965 19,753 (Loss) income from operations before income taxes (80,170 ) 32,865 (93,929 ) (30,838 ) 14,178 Income tax (benefit) expense (<em>111</em>",
"sentiment": -0.3182,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 1973,
"sentiment_avg": 0.2782416946818192
}
]
}
Other details
Country
- us
- 5,275